93% of leukaemia patients in remission after an experimental T cell therapy
Doctors are reporting "extraordinary" results after the first clinical trial of an experimental type of immunotherapy against advanced leukaemia. The new approach was tested on 29 late-stage leukaemia patients who'd exhausted all other options. After the therapy, 27 of them went into remission - that's an incredible 93 percent success rate. One patient who wasn't successful the first time around went into remission after a second, higher dose.